mutation in BRCA1 or BRCA2(English)

• these HGSOC patients are most responsive to PARP inhibitors
• BRCA, HGSOC, OC, PARP, VEGFR
• Genetics, Ovary and uterus, Oncology, Therapeutic approaches
• https://doi.org…84.2016.1156857